{
    "clinical_study": {
        "@rank": "67038", 
        "arm_group": {
            "arm_group_label": "Miconazole plus Hydrocortisone", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the efficacy and safety of miconazole plus\n      hydrocortisone cream in the treatment of participants with vulvar candidiasis (yeast\n      infection of the vulva)."
        }, 
        "brief_title": "An Efficacy and Safety Study of Miconazole and Hydrocortisone Cream in the Treatment of Vulvar Candidiasis", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": {
                        "@group_id": "B1", 
                        "description": "Participants applied miconazole plus hydrocortisone cream topically to the lesion twice daily up to Day 14. Treatment continued till Day 28, if signs and symptoms of vulvar candidiasis were not cured clinically on Day 14.", 
                        "title": "Miconazole Plus Hydrocortisone"
                    }
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "115"
                                        }
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@spread": "9.39", 
                                            "@value": "37.76"
                                        }
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "115"
                                            }
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "0"
                                            }
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed."
            }, 
            "limitations_and_caveats": "Data was not collected for pruritus symptom assessment by visual analog scale outcome measure as only few participants had pruritus after 1-hour of study drug application.", 
            "outcome_list": {
                "outcome": [
                    {
                        "description": "Time to itch relief is defined as time needed to achieve pruritus (itchiness) relief.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Participants applied miconazole plus hydrocortisone cream topically to the lesion twice daily up to Day 14. Treatment continued till Day 28, if signs and symptoms of vulvar candidiasis were not cured clinically on Day 14.", 
                                "title": "Miconazole Plus Hydrocortisone"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "115"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "1.41", 
                                                    "@value": "13.36"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Time to itch relief is defined as time needed to achieve pruritus (itchiness) relief.", 
                                    "dispersion": "Standard Error", 
                                    "param": "Mean", 
                                    "title": "Mean Time to Itch Relief", 
                                    "units": "minutes"
                                }
                            ]
                        }, 
                        "population": "Analysis population included all the participants who received at least 1 dose of study medication.", 
                        "safety_issue": "No", 
                        "time_frame": "1-hour after initial application", 
                        "title": "Mean Time to Itch Relief", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Participants were considered as clinically cured if the potassium hydroxide (KOH) mount / Gram stain (a method used to diagnose bacterial infection) test was negative for infection.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Participants applied miconazole plus hydrocortisone cream topically to the lesion twice daily up to Day 14. Treatment continued till Day 28, if signs and symptoms of vulvar candidiasis were not cured clinically on Day 14.", 
                                "title": "Miconazole Plus Hydrocortisone"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "74"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "97.30"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Participants were considered as clinically cured if the potassium hydroxide (KOH) mount / Gram stain (a method used to diagnose bacterial infection) test was negative for infection.", 
                                    "param": "Number", 
                                    "title": "Percentage of Participants Who Achieved Clinical Cure", 
                                    "units": "percentage of participants"
                                }
                            ]
                        }, 
                        "population": "Analysis population included all the participants who received at least 1 dose of study medication. Here 'N' (number of participants analyzed) signifies those participants who were evaluable for this measure.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline up to Day 28", 
                        "title": "Percentage of Participants Who Achieved Clinical Cure", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": {
                                "group_id_list": {
                                    "group_id": "O1"
                                }, 
                                "method": "t-test, 2 sided", 
                                "non_inferiority": "No", 
                                "p_value": "<0.0001"
                            }
                        }, 
                        "description": "The MISS is a specific instrument for assessing and quantifying the intensity of pruritus. The MISS score ranges from 0 to 21, where 0=no itching and 21=very severe itching.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Participants applied miconazole plus hydrocortisone cream topically to the lesion twice daily up to Day 14. Treatment continued till Day 28, if signs and symptoms of vulvar candidiasis were not cured clinically on Day 14.", 
                                "title": "Miconazole Plus Hydrocortisone"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "115"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "2.57", 
                                                        "@value": "7.25"
                                                    }
                                                }, 
                                                "sub_title": "Baseline (n=115)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "0.63", 
                                                        "@value": "4.27"
                                                    }
                                                }, 
                                                "sub_title": "Day 28 (n=7)"
                                            }
                                        ]
                                    }, 
                                    "description": "The MISS is a specific instrument for assessing and quantifying the intensity of pruritus. The MISS score ranges from 0 to 21, where 0=no itching and 21=very severe itching.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Modified Itch Severity Scale (MISS) Score", 
                                    "units": "units on a scale"
                                }
                            ]
                        }, 
                        "population": "Analysis Population included all the participants who received at least 1 dose of study medication. Here \u2018n\u2019 signifies those participants who were evaluable at specified time-point.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline and Day 28", 
                        "title": "Modified Itch Severity Scale (MISS) Score", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Pruritus is assessed by using a 100 millimeter (mm) of VAS score ranges from 0 to 100 mm, where 0 mm=no pruritus and 100 mm=worse pruritus.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Participants applied miconazole plus hydrocortisone cream topically to the lesion twice daily up to Day 14. Treatment continued till Day 28, if signs and symptoms of vulvar candidiasis were not cured clinically on Day 14.", 
                                "title": "Miconazole Plus Hydrocortisone"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "0"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Pruritus is assessed by using a 100 millimeter (mm) of VAS score ranges from 0 to 100 mm, where 0 mm=no pruritus and 100 mm=worse pruritus.", 
                                    "title": "Pruritus Symptom Assessment by Visual Analog Scale (VAS) Score"
                                }
                            ]
                        }, 
                        "population": "Data was not collected as only few participants had pruritus after 1-hour of study drug application.", 
                        "safety_issue": "No", 
                        "time_frame": "1-hour after initial application", 
                        "title": "Pruritus Symptom Assessment by Visual Analog Scale (VAS) Score", 
                        "type": "Secondary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": {
                        "@group_id": "P1", 
                        "description": "Participants applied miconazole plus hydrocortisone cream topically (applied to skin) to the lesion twice daily up to Day 14. Treatment continued till Day 28, if signs and symptoms of vulvar candidiasis (yeast infection of the vulva) were not cured clinically on Day 14.", 
                        "title": "Miconazole Plus Hydrocortisone"
                    }
                }, 
                "period_list": {
                    "period": {
                        "drop_withdraw_reason_list": {
                            "drop_withdraw_reason": [
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "42", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "Lost to Follow-up"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "1", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "Adverse Event"
                                }
                            ]
                        }, 
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "115", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "72", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "43", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }
            }, 
            "point_of_contact": {
                "name_or_title": "Medical Affairs Manager", 
                "organization": "Janssen Philippines", 
                "phone": "+6328248935"
            }, 
            "reported_events": {
                "group_list": {
                    "group": {
                        "@group_id": "E1", 
                        "description": "Participants applied miconazole plus hydrocortisone cream topically to the lesion twice daily up to Day 14. Treatment continued till Day 28, if signs and symptoms of vulvar candidiasis were not cured clinically on Day 14.", 
                        "title": "Miconazole Plus Hydrocortisone"
                    }
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "2", 
                                            "@subjects_at_risk": "115"
                                        }, 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "2", 
                                            "@subjects_at_risk": "115"
                                        }, 
                                        "sub_title": "Pruritus"
                                    }
                                }, 
                                "title": "Skin and subcutaneous tissue disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Non-systematic Assessment", 
                    "default_vocab": "MedDRA Version 15.1", 
                    "frequency_threshold": "0"
                }, 
                "time_frame": "From signing of informed consent until 30 days after the last dose of study medication"
            }
        }, 
        "completion_date": {
            "#text": "June 2009", 
            "@type": "Actual"
        }, 
        "condition": "Vulva; Candidiasis", 
        "condition_browse": {
            "mesh_term": "Candidiasis"
        }, 
        "detailed_description": {
            "textblock": "This is an open label (all people know the identity of the intervention), single-arm,\n      prospective (study following participants forward in time) study to evaluate the efficacy\n      and safety of miconazole plus hydrocortisone cream in participants with vulvar candidiasis.\n      Participants will be evaluated and assessed on the degree of pruritus (itchiness) and\n      screened for candidiasis on the baseline. Participants will apply the cream once enrolled\n      and will be assessed for 1-hour to get the time to relief. Each participant will apply the\n      study medication topically (applied to skin) to the lesion twice daily up to Day 14 by\n      rubbing gently until it has been completely penetrated into the vulvar area affected and the\n      treatment should be continued without interruption. Participants will be followed-up after\n      14 days and will be assessed clinically for signs and symptoms of vulvar candidiasis; if not\n      cured, participants will continue the medication up to Day 28. Primary efficacy endpoint\n      will be the time needed to achieve pruritus relief. Participants' safety will be monitored\n      throughout the study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria: - Positive potassium hydroxide (KOH) mount / Gram stain (a method used\n        to diagnose bacterial infection) of vulvar (the tissues around the opening to the vagina)\n        scrapings - Vulvar candidiasis with at least mild pruritus        Exclusion Criteria: -\n        Participants with vaginal candidiasis (yeast infection of the vagina) - History of allergy\n        to miconazone (an antifungal agent, is used for skin infections such as vaginal yeast\n        infections) and/or other components of the study drug - Pruritus caused by etiologic (the\n        cause) agents aside from fungi - Tuberculous (bacterial infection that usually results in\n        a serious lung disorder) skin infection - Herpes simplex (viral infection), vaccinia\n        (vaccine used to eradicate smallpox), all forms of varicella (infection caused by the\n        varicella-zoster virus), and vulvar malignancy (cancer)"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "115", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 14, 2013", 
        "firstreceived_results_date": "February 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01769339", 
            "org_study_id": "CR015721", 
            "secondary_id": "MICFUN4001"
        }, 
        "intervention": {
            "arm_group_label": "Miconazole plus Hydrocortisone", 
            "description": "Participants will apply miconazole plus hydrocortisone cream topically to the lesion twice daily up to Day 14 by rubbing gently until it has been completely penetrated into the affected vulvar (the tissues around the opening to the vagina) area and the treatment should be continued without interruption. Participants will be assessed for signs and symptoms of vulvar candidiasis at Day 14. Medication will be continued till Day 28, if signs and symptoms of vulvar candidiasis are not cured clinically on Day 14.", 
            "intervention_name": "Miconazole plus Hydrocortisone", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Miconazole", 
                "Clotrimazole", 
                "Cortisol succinate", 
                "Hydrocortisone acetate", 
                "Hydrocortisone 17-butyrate 21-propionate", 
                "Hydrocortisone", 
                "Hydrocortisone-17-butyrate"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Vulvar Candidiasis", 
            "Miconazole", 
            "Hydrocortisone", 
            "Daktacort Feminine Care Cream"
        ], 
        "lastchanged_date": "February 18, 2013", 
        "number_of_arms": "1", 
        "official_title": "Effectiveness and Safety of Daktacort Feminine Care Cream in the Treatment of Vulvar Candidiasis", 
        "overall_official": {
            "affiliation": "Janssen Pharmaceutica", 
            "last_name": "Janssen Pharmaceutica Clinical Trial", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Philippines : Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2009", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Time to itch relief is defined as time needed to achieve pruritus (itchiness) relief.", 
            "measure": "Mean Time to Itch Relief", 
            "safety_issue": "No", 
            "time_frame": "1-hour after initial application"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01769339"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Participants were considered as clinically cured if the potassium hydroxide (KOH) mount / Gram stain (a method used to diagnose bacterial infection) test was negative for infection.", 
                "measure": "Percentage of Participants Who Achieved Clinical Cure", 
                "safety_issue": "No", 
                "time_frame": "Baseline up to Day 28"
            }, 
            {
                "description": "The MISS is a specific instrument for assessing and quantifying the intensity of pruritus. The MISS score ranges from 0 to 21, where 0=no itching and 21=very severe itching.", 
                "measure": "Modified Itch Severity Scale (MISS) Score", 
                "safety_issue": "No", 
                "time_frame": "Baseline and Day 28"
            }, 
            {
                "description": "Pruritus is assessed by using a 100 millimeter (mm) of VAS score ranges from 0 to 100 mm, where 0 mm=no pruritus and 100 mm=worse pruritus.", 
                "measure": "Pruritus Symptom Assessment by Visual Analog Scale (VAS) Score", 
                "safety_issue": "No", 
                "time_frame": "1-hour after initial application"
            }
        ], 
        "source": "Janssen Pharmaceutica", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Janssen Pharmaceutica", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2009", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}